Pharmaceutical Articles

RSS | Login | Register

Congressional subcommittee hearing targets DTC advertising

Stephen McGuire May 09, 2008

The head of the House of Representatives Energy and Commerce subcommittee is calling for tougher restrictions on DTC television advertising for prescription drugs.

Panel against expanded Fentora approval

Stephen McGuire May 07, 2008

An FDA advisory panel ruled against expanded use of Cephalon's powerful pain reliever Fentora as a treatment for non-cancer patients.

Merck to axe 1,200 sales jobs

Ben Comer May 05, 2008

Merck announced plans to cut 1,200 sales jobs by the end of July. Affected employees will be notified by the end of May.

Eisai appoints president of US operations

Ben Comer May 05, 2008

Cynthia Schwalm has been appointed president of Eisai's commercial operations in the US, effective May 5. She will report to Lonnel Coats, president and COO, Eisai Corporation of North America.

Sales forces dwindle at top pharmas

Ben Comer May 01, 2008

In an Associated Press tally, seven out of the 12 companies surveyed reported reductions in work force by 10% or more since January 2007.

J&J merges Ortho Biotech, Centocor sales, slashes 400 jobs

Ben Comer May 01, 2008

Johnson & Johnson is consolidating sales and marketing personnel for Ortho Biotech and Centecor.

Wyeth chairman Robert Essner to retire

Ben Comer April 25, 2008

Robert Essner will retire as chairman on June 27th, 2008. Essner was the the CEO of Wyeth from May 2001 through January 2007.

Wyeth, Elan halt study of Alzheimer's vaccine

Stephen McGuire April 18, 2008

Wyeth and Elan have suspended a clinical study of their jointly developed Alzheimer's vaccine ACC-001 after a patient receiving the treatment was hospitalized for nearly two weeks with skin ulcers.

Crestor to benefit as ENHANCE smoke clears: survey

Stephen McGuire April 10, 2008

Expect AstraZeneca's Crestor to emerge as the big winner in the aftermath of Merck/Schering Plough's Vytorin debacle, primary care physicians (PCPs) said.

Takeda to buy Millennium for $8.8 billion

Stephen McGuire April 10, 2008

Takeda Pharmaceutical of Japan has announced plans to purchase US biotech firm Millennium Pharmaceuticals in a deal valued at nearly $9 billion.

« Previous

Most Emailed

Most Recent

RSS